0001562180-21-001509.txt : 20210223 0001562180-21-001509.hdr.sgml : 20210223 20210223175829 ACCESSION NUMBER: 0001562180-21-001509 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210219 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reeve Emma CENTRAL INDEX KEY: 0001680329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 21667153 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION STREET 2: 195 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-02-19 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001680329 Reeve Emma C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 false true false false Chief Financial Officer Common Stock 2021-02-19 4 M false 4010.00 8.04 A 4010.00 D Common Stock 2021-02-19 4 S false 4010.00 37.7102 D 0.00 D Common Stock 2021-02-22 4 M false 6260.00 8.04 A 6260.00 D Common Stock 2021-02-22 4 S false 6260.00 37.5996 D 0.00 D Stock Option (right to buy) 8.04 2021-02-19 4 M false 4010.00 0.00 D 2028-04-22 Common Stock 4010.00 18037.00 D Stock Option (right to buy) 8.04 2021-02-22 4 M false 6260.00 0.00 D 2028-04-22 Common Stock 6260.00 11777.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $37.54 to $37.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $37.50 to $37.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on April 23, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through April 23, 2022. /s/ Emma Reeve 2021-02-23